A long-acting insulin from Novo Nordisk was shown to have a greater risk of excessively lowering patients' blood sugar without offering better management of sugar levels or other benefits ...

Novo Nordisk is also pairing the long-acting insulin with its once-weekly GLP-1 agonist semaglutide in the COMBINE trials programme, which is due to complete in 2024, is also working on a glucose ...

Novo Nordisk has said that the introduction ... That suggests its top-selling insulin products like rapid-acting NovoRapid (insulin aspart), premix NovoMix (insulin aspart/insulin aspart protamine ...

The modernization of the plant is expected to create new jobs and boost the local economy while reinforcing Novo Nordisk's position as a leader in the global insulin market.

Novo Nordisk is discontinuing one ... Luckily, there are many alternative insulins, both rapid-acting and long-acting. Zilbermint highlights Lantus (insulin glargine) as a good option.

A team led by Novo Nordisk’s Rita Slaaby developed the glucose-responsive insulin, which is called NNC2215. The insulin in NNC2215 makes links to two moieties: a glucose-binding macrocycle and a ...

Novo Nordisk landed in hot water with the FDA following an inspection at one of the drugmaker’s key semaglutide and insulin manufacturing plants this past spring. | The FDA issued a ...

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...

Novo Nordisk’s modified insulin holds great ... the risk of hypoglycemia and partly covering the need for fast-acting insulin at mealtime,” the researchers said. “The combination of these ...

In 1985, Novo Nordisk pioneered production of recombinant human insulin in yeast. In 1999, we introduced rapid-acting and, in 2004, long-acting insulin analogues produced by genetic engineering ...

As a pioneer in diabetes care, Novo has been ... generic versions of human insulin also stand for these modern versions--only one biosimilar version of Lilly's rapid-acting insulin Humalog ...

Insulin Aspart is a rapid-acting product originally from multinational Novo Nordisk and is sold globally as NovoLog or NovoRapid. However, locally developed products are gaining in significance ...